Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TREATMENT OF CANCER BY MEANS OF ADMINISTRATION OF LIGAND-MEDICAMENT CONJUGATE
Document Type and Number:
WIPO Patent Application WO/2024/099387
Kind Code:
A1
Abstract:
Provided is use of a ligand-medicament conjugate in the treatment of cancer, further, use of a ligand-medicament conjugate in the preparation of a medicament for treating platinum-resistant advanced epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer.

Inventors:
TENG YAN (CN)
YU JIANGANG (CN)
Application Number:
PCT/CN2023/130704
Publication Date:
May 16, 2024
Filing Date:
November 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
COHERENT BIOPHARMA SUZHOU LTD (CN)
International Classes:
A61K47/64; A61P35/00
Foreign References:
CN108135881A2018-06-08
CN102030754A2011-04-27
CN106279212A2017-01-04
CN111093706A2020-05-01
Other References:
TURK, M.J. ET AL.: "Folate-conjugated Liposomes Preferentially Target Macrophages Associated with Ovarian Carcinoma", CANCER LETTERS, vol. 213, 31 December 2004 (2004-12-31), pages 165 - 172, XP004536129, DOI: 10.1016/j.canlet.2003.12.028
YANG XIAOQIANG, GRAILER JAMISON J.; ROWLAND IAN J.; JAVADI ALIREZA; HURLEY SAMUEL A.; MATSON VYARA Z.; STEEBER DOUGLAS A.; GONG SH: "Multifunctional Stable and pH-Responsive Polymer Vesicles Formed by Heterofunctional Triblock Copolymer for Targeted Anticancer Drug Delivery and Ultrasensitive MR Imaging", ACS NANO, AMERICAN CHEMICAL SOCIETY, US, vol. 4, no. 11, 23 November 2010 (2010-11-23), US , pages 6805 - 6817, XP093172110, ISSN: 1936-0851, DOI: 10.1021/nn101670k
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: